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Inflammatory and infectious diseases may have serious con-
sequences for the patient, if not diagnosed in time. In the 
past decades, nuclear medicine modalities have allowed us to 
study in depth the pathophysiology of these processes, and 
today it plays a leading role in the diagnosis, characterization 
and follow-up of infectious conditions.
Different nuclear medicine techniques and radiopharma-
ceuticals are currently available for imaging inflammation 
and infection (including gallium-citrate, radiolabelled white 
blood cells, anti-granulocyte antibodies and FDG) and it is, 
therefore, essential for nuclear medicine physicians to have 
a complete vision of pros and cons of each method and to 
know how to correctly position nuclear medicine examina-
tions in the diagnostic workup of patients [1–4].
Despite the relevance of nuclear medicine in the field 
of diagnosis of infectious processes, we observe impor-
tant differences in diagnostic accuracy of nuclear medicine 
techniques, between different centres and between different 
nations. Differences concern the choice of diagnostic pro-
cedures to be performed, how these are performed and how 
results are interpreted. Because of different methodology 
and different interpretation criteria, conflicting data with 
wide variability of diagnostic accuracy have been published 
in the past decades. This variability has not favoured, over 
the years, the diffusion among the clinicians of the most 
common methods of nuclear medicine for the diagnosis of 
infections, such as, for example, the use of radiolabelled 
autologous leukocytes, or the use of monoclonal anti-gran-
ulocyte antibodies or the use of fluordeoxyglucose. This is 
even more evident, if we look at the results published in 
recent meta-analyses [5–8]. As a consequence, clinicians 
have turned mainly to radiological diagnostic investigations 
(CT, NMR and ultrasound) although not always optimal 
in the assessment of the extent and activity of the infec-
tious disease, nor useful in the follow-up of therapies unlike 
nuclear medical methods.
Therefore, since its creation, in 2012, the EANM Com-
mittee on Inflammation and Infection has worked on three 
main goals: (1) the standardization of nuclear medicine tech-
niques for the diagnosis of infection and/or inflammation 
and their interpretation criteria, (2) the divulgation of these 
techniques amongst nuclear medicine physicians and (3) the 
preparation and divulgation of joint diagnostic guidelines 
with clinicians.
To reach the first goal, several procedural guidelines 
have been published about how to label autologous white 
blood cells (WBC) with 99mTc-HMPAO [9] or with 111In-
oxine [10] and about the quality controls that should be 
performed for the initial validation of the procedure by 
each centre and on a routine base. Similarly, a guideline 
on the use of  [18F]FDG in inflammation/infection has 
been published in 2013 in collaboration with SNMMI 
[11]. Finally, in the beginning of 2018 the members of 
the EANM Committee on Inflammation and Infection, 
in some cases together with other committees and socie-
ties, published other important procedural guidelines on 
multimodality imaging for infective endocarditis [12], for 
large vessel vasculitis and polymyalgia rheumatica [13], 
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for cardiac sarcoidosis [14, 15] and on acquisition and 
interpretation criteria for WBC and anti-granulocyte imag-
ing in infections [16].
The aim of all these guidelines is to reach a worldwide 
standardization of imaging modalities and patient prepara-
tion, but also a standardization on image acquisition and 
display parameters and on interpretation criteria.
This is extremely important for our discipline since the 
use of correct acquisition protocols will lead to good and 
accurate scans. Furthermore, using standardized interpreta-
tion criteria will lead to reliable and reproducible reports to 
clinicians that will increase our visibility, role and reliability.
Particularly in the field of infection, almost every centre 
had a slightly different procedure for WBC labelling and 
for protocols of image acquisition and interpretation. We, 
therefore, absolutely needed to standardize these techniques, 
to provide top quality examinations.
The second goal of divulgation was reached by organising 
courses and congresses dedicated to imaging of infection 
and inflammation. The EANM website also hosts several 
webinars that can be downloaded. Indeed, the new organi-
zation of the European School of Molecular Imaging and 
Therapy (ESMIT) includes a level 1 teaching program based 
on webinars, a level 2 teaching program based on courses in 
which infection/inflammation imaging is included particu-
larly in the musculoskeletal and cardio-vascular system, and 
a level 3 teaching program of advanced courses in selected 
topics, amongst which, the WBC labelling.
After accomplishing these two goals, we were ready to 
approach several other European societies to prepare, jointly, 
diagnostic guidelines. We approached several societies, the 
European Crohn’s and Colitis Organization (ECCO), the 
European Society of Gastrointestinal Radiology (ESGAR), 
the European Society of Cardiology (ESC), the European 
Society of Radiology (ESR), the European Society of Vas-
cular Surgery (ESVS), the European Association for the 
Study of Diabetes (EASD), the European Society of Clinical 
Microbiology and Infective Diseases (ESCMID), the Euro-
pean League Against Rheumatism (EULAR), the European 
Bone and Joint Infection Society (EBJIS) and the European 
Society of NeuroRadiology (ESNR), as shown in Fig. 1.
With these societies, we organized several symposia and 
congresses all over Europe and we published in 2015 a mon-
ographic issue with a proposal of diagnostic flow charts for 
the most relevant inflammatory/infective diseases [17–21].
In the last 3 years, the Committee also started several 
evidence-based guidelines (as shown in Fig. 1) of which two 
(on infective endocarditis and inflammatory bowel diseases) 
have been already published [22, 23] and others (prosthetic 
joint infection, peripheral bone infection, spondylodiscitis, 
vascular graft infection, and infected diabetic foot) will soon 
be submitted to clinical journals.
With a huge multidisciplinary effort, we reached unani-
mous consensus to standardize the diagnostic approach in 
patients with infectious/inflammatory diseases. This consen-
sus has an impact for correct patient management and to 
harmonize and increase the efficacy of national health care.
Fig. 1  The network of collabo-
rations established over the last 
6 years by the EANM Commit-
tee on inflammation/infection 
and other European societies
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